CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $87.19B, higher than 95% of all stocks globally
- FinancialsAltman Z-Score 2.55: grey zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.45%Above 5Y avg (1.62%)
Annual Rate
EUR 4.00Paid annual
Payout Ratio
74.8%Moderate
Payback Period
40.8 yr
Last Ex-Dividend
May 5, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
75.33BEUR87.19B · vs all stocks (USD)
Trailing P/E
29.87xvs Medical Instruments & Supplies peers
Revenue (TTM)
29.28BEUR33.90B · vs all stocks (USD)
Profit Margin
8.52%vs Medical Instruments & Supplies peers
Beta
0.5490xvs all stocks
52-Week Change
-40.89%vs all stocks
Market Capitalization
75.33BEUR87.19B · vs all stocks (USD)
Enterprise Value
87.54BEUR101.33B · vs all stocks (USD)
Trailing P/E
29.87xvs Medical Instruments & Supplies peers
Forward P/E
19.68xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
2.51xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.87xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.99xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
14.96xvs Medical Instruments & Supplies peers
Profit Margin
8.52%vs Medical Instruments & Supplies peers
Operating Margin
15.37%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
3.69%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
6.72%vs Medical Instruments & Supplies peers
Revenue (TTM)
29.28BEUR33.90B · vs all stocks (USD)
Revenue per Share (TTM)
63.46EURUpdated Aug 19, 2026Quarterly Revenue Growth
5.70%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
17.58BEUR20.35B · vs all stocks (USD)
EBITDA (TTM)
6.60BEUR7.63B · vs all stocks (USD)
Net Income (TTM)
2.49BEUR2.89B · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
12.90%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
5.29BEUR6.12B · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.29BEUR3.80B · vs all stocks (USD)
Trailing Annual Dividend Rate
4.00EURUpdated Aug 19, 2026Trailing Annual Dividend Yield
2.45%vs all stocks
5-Year Average Dividend Yield
1.62%vs all stocks
Payout Ratio
74.77%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
604.00MEURFY2025 · Dec 31, 2025Revenue
28.49BEURFY2025 · Dec 31, 2025Cost of Goods Sold
11.24BEURFY2025 · Dec 31, 2025Gross Profit
17.25BEURFY2025 · Dec 31, 2025Operating Income
3.38BEUR3.91B · vs all stocks (USD)
Pre-tax Income
3.19BEURFY2025 · Dec 31, 2025Income Tax Expense
752.00MEURFY2025 · Dec 31, 2025Net Income
2.44BEURFY2025 · Dec 31, 2025EBIT
3.51BEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
6.60BEURFY2025 · Dec 31, 2025Research & Development
664.00MEURFY2025 · Dec 31, 2025Selling, General & Administrative
12.98BEURFY2025 · Dec 31, 2025Other Operating Expenses
249.00MEURFY2025 · Dec 31, 2025Non-operating Interest Income
85.00MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
314.00MEURFY2025 · Dec 31, 2025EPS (Basic)
5.04EURFY2025 · Dec 31, 2025EPS (Diluted)
4.98EURFY2025 · Dec 31, 2025Basic Shares Outstanding
459.02MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
459.02MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
2.44BEURFY2025 · Dec 31, 2025Minority Interests (P&L)
-128.00MEURFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00EURFY2025 · Dec 31, 2025Operating Cash Flow
2.44BEURFY2025 · Dec 31, 2025Free Cash Flow
922.00MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.54BEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.44BEURFY2025 · Dec 31, 2025Stock-based Compensation
280.00MEURFY2025 · Dec 31, 2025Other Non-cash Items
158.00MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-446.00MEURFY2025 · Dec 31, 2025Capital Expenditures
-1.51BEURFY2025 · Dec 31, 2025Net Acquisitions
-911.00MEURFY2025 · Dec 31, 2025Other Investing Activity
12.00MEURFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.41BEURFY2025 · Dec 31, 2025Long-term Debt Issuance
992.00MEURFY2025 · Dec 31, 2025Long-term Debt Payments
-2.47BEURFY2025 · Dec 31, 2025Net Short-term Debt Issuance
1.50BEURFY2025 · Dec 31, 2025Common Stock Repurchase
-376.00MEURFY2025 · Dec 31, 2025Common Dividends Paid
-547.00MEURFY2025 · Dec 31, 2025Other Financing Charges
1.42BEURFY2025 · Dec 31, 2025Net Financing Cash Flow
556.00MEURFY2025 · Dec 31, 2025Shares Outstanding
459.59MSharesUpdated Aug 19, 2026Float Shares
292.07MSharesUpdated Aug 19, 2026% Held by Insiders
36.99%vs all stocks
% Held by Institutions
28.08%vs all stocks
Total Cash (MRQ)
1.93BEUR2.24B · vs all stocks (USD)
Total Cash per Share (MRQ)
4.20EURUpdated Aug 19, 2026Total Debt (MRQ)
15.32BEUR17.73B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3836xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
0.8890xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
85.33EURUpdated Aug 19, 2026Total Assets
63.90BEUR73.96B · vs all stocks (USD)
Total Current Assets
12.01BEURFY2025 · Dec 31, 2025Total Liabilities
24.40BEURFY2025 · Dec 31, 2025Total Non-current Assets
51.89BEURFY2025 · Dec 31, 2025Total Non-current Liabilities
13.50BEURFY2025 · Dec 31, 2025Total Current Liabilities
10.90BEURFY2025 · Dec 31, 2025Cash
3.16BEURFY2025 · Dec 31, 2025Cash Equivalents
386.00MEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.54BEURFY2025 · Dec 31, 2025Accounts Receivable
3.64BEURFY2025 · Dec 31, 2025Inventory
3.54BEURFY2025 · Dec 31, 2025Accounts Payable
2.88BEURFY2025 · Dec 31, 2025Short-term Debt
3.68BEURFY2025 · Dec 31, 2025Other Current Liabilities
1.56BEURFY2025 · Dec 31, 2025Long-term Debt
10.71BEURFY2025 · Dec 31, 2025Other Non-current Liabilities
34.00MEURFY2025 · Dec 31, 2025Common Stock (Book)
83.00MEURFY2025 · Dec 31, 2025Retained Earnings
2.31BEURFY2025 · Dec 31, 2025Total Shareholders' Equity
39.49BEUR45.71B · vs all stocks (USD)
Treasury Stock
25.00MEURFY2025 · Dec 31, 202552-Week Low
159.20EURUpdated Aug 19, 202652-Week High
323.80EURUpdated Aug 19, 202652-Week Change
-40.89%vs all stocks
Beta
0.5490xvs all stocks
50-Day MA
170.28EURUpdated Aug 19, 2026200-Day MA
220.19EURUpdated Aug 19, 2026Avg 10-Day Volume
688.45KSharesUpdated Aug 19, 2026Avg 30-Day Volume
674.51KSharesUpdated Aug 19, 2026Diluted EPS (TTM)
5.35EURUpdated Aug 19, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.55: grey zoneSignificant
Altman Z-Score: 2.55
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $87.19B, higher than 95% of all stocks globallySignificant
Market cap (USD): 87,191,065,636.995Global P95: 25,614,208,870.135
Revenue is $33.9B, higher than 95% of all stocks globallySignificant
Revenue (USD): 33,897,386,536.96Global P95: 14,667,937,174.886
Levered free cash flow is $3.8B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 3,803,255,643.52Global P95: 1,123,592,359.78
Companies that share the same coordination system — how they create, deliver, or capture value.
Johnson Controls International plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Eoptolink Technology Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Cummins Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Hygon Information Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Constellation Energy Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Semiconductor Manufacturing International Corporation
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
3M Company
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Marathon Petroleum Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Phillips 66
Tier 1ProductionThroughput-Bound ConversionFlowRule
Valero Energy Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Cyrela Brazil Realty S.A. Empreendimentos e Participações
3 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated
Doctorglasses Chain Co. Ltd.
3 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated
Intuitive Surgical, Inc.
3 interpretationsRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin Elevated